Literature DB >> 3731686

Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans.

D S Goldstein, R Zimlichman, R Stull, H R Keiser.   

Abstract

We infused isoproterenol (ISO) intravenously into 23 subjects (3.5, 7, 14, and 35 ng/kg/min for 20 minutes at each dose) and measured venous plasma concentrations of ISO and the circulatory and plasma norepinephrine (NE) and epinephrine (E) responses. At the lowest dose, venous plasma ISO averaged 48 pg/ml and was associated with increased heart rate (9%; P less than 0.001), cardiac index (20%; P less than 0.001), and stroke volume (9%; P less than 0.02) and decreased total peripheral resistance index (-21%; P less than 0.001). Linear concentration-response relationships were observed between plasma ISO and cardiac index and between plasma ISO and heart rate. Plasma NE increased as a function of plasma ISO (mean increase 81% at 35 ng/kg/min), whereas plasma E was unchanged or decreased. The results indicate that circulatory effects of ISO are detectable in humans at plasma concentrations in the range of physiologic levels of E. Since ISO increases plasma NE, ISO may act presynaptically to enhance NE release from sympathetic nerve terminals and thereby stimulate alpha-adrenoceptors indirectly. ISO does not appear to stimulate secretion from the adrenal medulla or corelease of E with NE from sympathetic nerve endings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731686     DOI: 10.1038/clpt.1986.168

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

2.  Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

Authors:  Satyam Sarma; Douglas Stoller; Joseph Hendrix; Erin Howden; Justin Lawley; Sheryl Livingston; Beverley Adams-Huet; Courtney Holmes; David S Goldstein; Benjamin D Levine
Journal:  Circ Heart Fail       Date:  2020-03-13       Impact factor: 8.790

Review 3.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

4.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

5.  Insulin responses to glucose and isoproterenol decrease with age.

Authors:  James M Watters
Journal:  Can J Surg       Date:  2005-04       Impact factor: 2.089

6.  Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.

Authors:  J Ludwig; T Halbrügge; G Vey; J Walter; K H Graefe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Authors:  David S Goldstein; Oladi Bentho; Mee-Yeong Park; Yehonatan Sharabi
Journal:  Exp Physiol       Date:  2011-09-02       Impact factor: 2.969

8.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

9.  Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.

Authors:  G Eisenhofer; H S Cox; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

Review 10.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.